SHAREHOLDER ALERT: Kiromic Biopharma, Inc. (KRBP) Officers and Directors Under Investigation for Possible False Statements About Its Commercial Prospects

/PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Kiromic Biopharma, Inc. (NASDAQ: KRBP)...

Related Keywords

Kiromic Biopharma ,Kiromic Biopharma Inc ,Prnewswire Schubert Jonckheer Kolbe ,Schubert Firm ,Drug Administration ,Nasdaq ,Schubert Jonckheer Amp Kolbe Llp ,